Nuzenio

Vera Therapeutics Announces

Vera Therapeutics Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 14:00:27 GMTSilence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine Media
Mon, 10 Aug 2026 11:30:00 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business Wire
Fri, 07 Aug 2026 20:05:00 GMTVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Fri, 07 Aug 2026 15:11:14 GMTState Street Corporation (VERA) discloses 4.1M-share stake in Vera Therapeutics - Stock Titan
Wed, 05 Aug 2026 20:14:31 GMTEquity awards for Vera Therapeutics (VERA) Chief Regulatory Officer - Stock Titan
Thu, 30 Jul 2026 15:19:43 GMTBlackRock (NYSE: BLK) discloses 5.34M-share Vera Therapeutics (VERA) stake - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Vera Therapeutics Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.